Holen Sie sich die Stockscreener-App
14.39
1.09%
-0.1585
Schlusskurs vom Vortag:
$14.55
Offen:
$14.42
24-Stunden-Volumen:
256
Relative Volume:
0.02
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-8.54%
1M Leistung:
-12.96%
6M Leistung:
-13.17%
1J Leistung:
-5.34%
1-Tages-Spanne:
$14.42
$14.42
1-Wochen-Bereich:
$14.42
$15.89
52-Wochen-Spanne:
$14.05
$25.87
Proshares Ultrashort Nasdaq Biotechnology 2 X Shares Stock (BIS) Company Profile
Firmenname
Proshares Ultrashort Nasdaq Biotechnology 2 X Shares
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie BIS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BIS
Proshares Ultrashort Nasdaq Biotechnology 2 X Shares
|
14.42 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
316.85 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
644.45 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
647.55 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
245.75 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
578.72 | 124.43B | 0 | 0 | 0 | 0.00 |
Proshares Ultrashort Nasdaq Biotechnology 2 X Shares Aktie (BIS) Neueste Nachrichten
Will Bluerock Homes Trust Inc. continue its uptrendTechnical Analysis of Growth Stock Opportunities - Newser
Custom watchlist performance reports with RNR.PRGAI Intraday Market Movement Prediction Tool - Newser
Analyzing net buyer seller activity in ETRACS 2x Leveraged US Growth Factor TR ETNBollinger Band Squeeze and Expansion Analysis - Newser
Why is VCEL stock attracting strong analyst attentionBuild wealth steadily with expert advice - Jammu Links News
How strong is ProShares Trust ProShares UltraShort Nasdaq Biotechnology company’s balance sheetOutstanding capital returns - Jammu Links News
Is BlackRock Energy and Resources Trust a good long term investmentAchieve rapid portfolio growth with expert help - Jammu Links News
Is it the right time to buy PMVP stockPowerful growth strategies - Jammu Links News
Is ProShares Trust ProShares UltraShort Nasdaq Biotechnology a good long term investmentUnstoppable trading performance - Jammu Links News
What institutional investors are buying Ferrovial SE stockSkyrocketing returns - Jammu Links News
What catalysts could drive SDGR stock higher in 2025Get timely alerts on market opportunities - Jammu Links News
How does FISI generate profit in a changing economyOutperformance with explosive growth - Jammu Links News
Why is Archer Aviation Inc. Equity Warrant stock attracting strong analyst attentionAchieve rapid capital gains with smart investing - Jammu Links News
Is InterCure Ltd. a growth stock or a value stockAchieve superior capital gains with smart trades - Jammu Links News
Is ProShares Trust ProShares UltraShort Nasdaq Biotechnology stock overvalued or undervaluedConsistently profitable trades - Jammu Links News
How many analysts rate 36Kr Holdings Inc. Depositary Receipt as a “Buy”Achieve exceptional returns with expert guidance - Jammu Links News
How does Abacus Global Management Inc. compare to its industry peersUnlock daily stock market insights for success - Jammu Links News
What markets is FRGT expanding into Is Oculis Holding AG stock a good long term investment option - Jammu Links News
Is HIVE Digital Technologies Ltd. a growth stock or a value stockMarket Forecast Tips With Proven Results - jammulinksnews.com
How strong is ON24 Inc. company’s balance sheetLow Risk Watchlist With High Returns - Jammu Links News
Resorts Inc. generate profit in a changing economyMarket Forecast Alerts Backed By Experts - Jammu Links News
What is ProShares Trust ProShares UltraShort Nasdaq Biotechnology company’s growth strategyMarket Forecast Target Finder For 2025 - Jammu Links News
Does First National Corporation stock perform well during market downturnsMarket Forecast Target Finder For 2025 - Jammu Links News
What makes ProShares Trust ProShares UltraShort Nasdaq Biotechnology stock price move sharplyBeginner Investor Strategy With Proven Results - jammulinksnews.com
When is ProShares Trust ProShares UltraShort Utilities stock expected to show significant growthCapitalize on fast-growing investment opportunities - Jammu Links News
What markets is CRGX expanding into Is EBAYL stock a good long term investment optionPhenomenal capital appreciation - Jammu Links News
Should I hold or sell HSBC stock in 2025Unlock daily market insights for better trades - Jammu Links News
What are the latest earnings results for Abrdn Life Sciences InvestorsAchieve consistent profits with proven methods - Jammu Links News
What is the dividend policy of ProShares Trust ProShares UltraShort Nasdaq Biotechnology stockInvest confidently with daily market forecasts - jammulinksnews.com
What are ProShares Trust ProShares UltraShort Nasdaq Biotechnology company’s key revenue driversInvest confidently with professional market insights - Jammu Links News
How volatile is OILU stock compared to the marketConsistently exceptional gains - Jammu Links News
Is ProShares Trust ProShares Ultra Nasdaq Biotechnology a growth stock or a value stockFree Stock Index Interpretation - Jammu Links News
Is MNTSW a growth stock or a value stockConsistently exceptional gains - jammulinksnews.com
Investing in Automobile Sector Market Expert Stock InsightsFree High-Return Strategy Alerts - PrintWeekIndia
What drives Cabaletta Bio Inc. stock priceRapid market gains - PrintWeekIndia
ProShares Trust ProShares UltraShort Nasdaq Biotechnology Stock Analysis and ForecastRapid profit acceleration - PrintWeekIndia
Indo Us Bio (INDOUS) Stock RalliesAccelerated earnings growth - Autocar Professional
Is MLACR stock a growth or value playSuperior returns - jammulinksnews.com
Is Drilling Tools International Corporation stock a growth or value playFree Wealth Planning Blueprint - jammulinksnews.com
What analysts say about LOCO stockFree Stock Market Real-Time Monitoring - Autocar Professional
Finanzdaten der Proshares Ultrashort Nasdaq Biotechnology 2 X Shares-Aktie (BIS)
Es liegen keine Finanzdaten für Proshares Ultrashort Nasdaq Biotechnology 2 X Shares (BIS) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.02%
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):